Distinguished from other cells by virtue of being unspecialized cells capable of renewing themselves through cell division, stem cells have demonstrated to have the potential to develop into many different cell types in the body during early life and growth. Indeed, under certain physiologic conditions they can be induced to become tissue or organ-specific cells with particular functions, thus serving as an internal repair system, dividing to replenish other cells. Stem cell therapeutics emerges as a new alternative to address most concern healthcare issues, especially for diseases that are currently inadequately treated or for which no therapeutic options exist. Remarkable, stem cells have the potential to cure diseases by stimulating the regeneration of healthy tissue in areas of damage. This fact represents an important advantage over pharmaceuticals, which typically treat the symptoms of a disorder. Beyond therapeutics, stem cells are becoming an extremely important tool for drug toxicity assays so that drug-safety issues can be detected in petri dishes before they get translated to patients. In fact, most commercialization strategies are focused on producing research tools for developing these cell lines.
About this report
The scope of this research service comprises research within the area of adult and embryonic stem cells, and developments in the nascent area of induced pluripotent stem cells. While it will be next to impossible to capture all the developments in this area, this research service profiles some global developments in the area of stem cells. Popular technologies, path-breaking research, and excellent initiatives in the area of biomarker discovery and its applications from different parts of the world--including the United States, Canada, Germany, UK, Belgium, and Australia--have been covered
Electronic Access - Site License Fulfilled by Publisher
Electronic Access - Global site License Fulfilled By Publisher